Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Windsor

$25,000.00

Development of Nanobubbles and Glycoliposomes as Innovative Nanomaterials and Drug Delivery Platforms for Improving Hydrophobic Pharmaceutical Solubility in Water

FY 2017-18

Summary
Many effective drugs are hydrophobic, meaning they do not dissolve well in water, this allows them to interact very well withenzymes and proteins in the body. Critical Outcome Technologies (COT) has a number of hydrophobic drugs in itspharamaceutical pipeline, and requires new types of nanomaterial drug delivery platforms to improve solubility. COT is teaming up with the Trant lab at the University of Windsor, experts in chemistry, at the University of Windsor to develop entirely new classes of nanomaterials that can help stabilize hydophobic compounds in water solutions. The collaborators will look at using two types of innovative nanotechnology, nanobubbles, tiny oxygen bubbles, and glycoliposomes (nano-sized fat globules with sugars on the surface that can target particular cell types) as new solutions to this old problem. This will mean that these different types of drugs will be able to be used to help Canadians, and the partners expect these strategies to be applicable to a wide variety of different compounds. This project brings together COTs expertise in the pharmaceutical business and knowledge of the market, with UWindsors expertise in chemistry and research development. It is expected to result in the development of new drug delivery platforms for COTs pharmaceutical pipeline and to help the company expand this part of their business in recovering previously shelved drugs that showed promising activity but insufficient water solubility. This partnership is expected to create a new technology while also leading to the creation of new high-quality research and development jobs in Ontario.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
519843-2017
Name nom
Trant, John
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3402
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Surface and interfacial chemistry
Research subject fr
Chimie des surfaces et des interfaces
Partie
1
Nb partie
1
Application title
Development of Nanobubbles and Glycoliposomes as Innovative Nanomaterials and Drug Delivery Platforms for Improving Hydrophobic Pharmaceutical Solubility in Water
Keyword
NSERC
Application summary
Many effective drugs are hydrophobic, meaning they do not dissolve well in water, this allows them to interact very well withenzymes and proteins in the body. Critical Outcome Technologies (COT) has a number of hydrophobic drugs in itspharamaceutical pipeline, and requires new types of nanomaterial drug delivery platforms to improve solubility. COT is teaming up with the Trant lab at the University of Windsor, experts in chemistry, at the University of Windsor to develop entirely new classes of nanomaterials that can help stabilize hydophobic compounds in water solutions. The collaborators will look at using two types of innovative nanotechnology, nanobubbles, tiny oxygen bubbles, and glycoliposomes (nano-sized fat globules with sugars on the surface that can target particular cell types) as new solutions to this old problem. This will mean that these different types of drugs will be able to be used to help Canadians, and the partners expect these strategies to be applicable to a wide variety of different compounds. This project brings together COTs expertise in the pharmaceutical business and knowledge of the market, with UWindsors expertise in chemistry and research development. It is expected to result in the development of new drug delivery platforms for COTs pharmaceutical pipeline and to help the company expand this part of their business in recovering previously shelved drugs that showed promising activity but insufficient water solubility. This partnership is expected to create a new technology while also leading to the creation of new high-quality research and development jobs in Ontario.
University of Windsor - $25,000 Grant (2017-18) | Canada Spends